September 23, 2022

The COVID-19 pandemic had a huge impact on the pharmaceutical industry; it disrupted supply chains, delayed production and led to a shortage of medicines. In fact, it’s estimated that close to half of acute care medicines – which includes antibiotics, sedatives and blood thinners – were low in supply during the peak of the pandemic.